BORN study: a multicenter randomized trial investigating cord blood red blood cell transfusions to reduce the severity of retinopathy of prematurity in extremely low gestational age neonates

医学 早产儿视网膜病变 胎龄 脐带 脐带血 随机对照试验 新生儿学 儿科 贫血 输血 随机化 怀孕 产科 外科 内科学 免疫学 生物 遗传学
作者
Luciana Teofili,Patrizia Papacci,Nicoletta Orlando,Maria Bianchi,Tina Pasciuto,Iolanda Mozzetta,Fernando Palluzzi,Luciano Giacò,Carmen Giannantonio,Giulia Remaschi,Michela Santosuosso,Enrico Beccastrini,Marco Fabbri,Caterina Giovanna Valentini,Tiziana Bonfini,Eleonora Cloclite,Patrizia Accorsi,Antonella Dragonetti,Francesco Cresi,Giulia Ansaldi,Genny Raffaeli,Stefania Villa,Giulia Pucci,Isabella Mondello,Michele Santodirocco,Stefano Ghirardello,Giovanni Vento
出处
期刊:Trials [Springer Science+Business Media]
卷期号:23 (1) 被引量:11
标识
DOI:10.1186/s13063-022-06949-8
摘要

Abstract Background Extremely low gestational age neonates (ELGANs, i.e., neonates born before 28 weeks of gestation) are at high risk of developing retinopathy of prematurity (ROP), with potential long-life visual impairment. Due to concomitant anemia, ELGANs need repeated red blood cell (RBC) transfusions. These produce a progressive replacement of fetal hemoglobin (HbF) by adult hemoglobin (HbA). Furthermore, a close association exists between low levels of HbF and severe ROP, suggesting that a perturbation of the HbF-mediated oxygen release may derange retinal angiogenesis and promote ROP. Methods/design BORN (umBilical blOod to tRansfuse preterm Neonates) is a multicenter double-blinded randomized controlled trial in ELGANs, to assess the effect of allogeneic cord blood RBC transfusions (CB-RBCs) on severe ROP development. Recruitment, consent, and randomization take place at 10 neonatology intensive care units (NICUs) of 8 Italian tertiary hospitals. ELGANs with gestational age at birth comprised between 24+0 and 27+6 weeks are randomly allocated into two groups: (1) standard RBC transfusions (adult-RBCs) (control arm) and (2) CB-RBCs (intervention arm). In case of transfusion need, enrolled patients receive transfusions according to the allocation arm, unless an ABO/RhD CB-RBC is unavailable. Nine Italian public CB banks cooperate to make available a suitable amount of CB-RBC units for all participating NICUs. The primary outcome is the incidence of severe ROP (stage 3 or higher) at discharge or 40 weeks of postmenstrual age, which occurs first. Discussion BORN is a groundbreaking trial, pioneering a new transfusion approach dedicated to ELGANs at high risk for severe ROP. In previous non-randomized trials, this transfusion approach was proven feasible and able to prevent the HbF decrease in patients requiring multiple transfusions. Should the BORN trial confirm the efficacy of CB-RBCs in reducing ROP severity, this transfusion strategy would become the preferential blood product to be used in severely preterm neonates. Trial registration ClinicalTrials.gov NCT05100212. Registered on October 29, 2021

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
1秒前
Monroe完成签到 ,获得积分10
1秒前
柠栀给柠栀的求助进行了留言
1秒前
1秒前
2秒前
韩小青完成签到,获得积分10
2秒前
3秒前
ren完成签到,获得积分10
4秒前
luo完成签到,获得积分10
4秒前
4秒前
不弃发布了新的文献求助10
6秒前
ubless607的应助被Green采纳,获得10
6秒前
6秒前
搞怪的芾完成签到,获得积分10
7秒前
7秒前
兜里面有怪兽完成签到,获得积分10
8秒前
8秒前
晨昏蒙影完成签到 ,获得积分10
9秒前
一秋一年完成签到,获得积分10
9秒前
maoweicao完成签到,获得积分10
9秒前
swslgd完成签到,获得积分10
10秒前
12秒前
利妥昔单抗n完成签到,获得积分10
12秒前
长脑子的怼怼完成签到 ,获得积分10
13秒前
yyy完成签到 ,获得积分10
13秒前
14秒前
自然自行车完成签到,获得积分10
14秒前
jiangjiang完成签到,获得积分10
15秒前
神奇高乐高完成签到 ,获得积分10
16秒前
畅快季节完成签到,获得积分20
16秒前
王木木完成签到 ,获得积分10
17秒前
17秒前
cccxxx完成签到,获得积分10
17秒前
小飞完成签到,获得积分10
17秒前
18秒前
19秒前
嘟嘟豆806完成签到 ,获得积分0
20秒前
春暖花开完成签到 ,获得积分10
21秒前
立冬完成签到,获得积分10
22秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8190438
求助须知:如何正确求助?哪些是违规求助? 9577668
关于积分的说明 21853638
捐赠科研通 7789450
什么是DOI,文献DOI怎么找? 3436407
关于科研通互助平台的介绍 2560224
邀请新用户注册赠送积分活动 2483032